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Abstract
Introduction: Fibromuscular dysplasia is a non-atherosclerotic, non-inflammatory disease that most commonly affects 
the renal and internal carotid arteries.
Case presentation: We present the case of a 44-year-old Caucasian man who was admitted with complaints of loin 
pain and hypertension. A computed tomography scan of the abdomen revealed a right renal infarction with a nodular 
aspect of the right renal artery. Subsequent renal angiography revealed a typical 'string of beads' pattern of the right 
renal artery with thrombus formation. Oral anticoagulation was started and the secondary hypertension was easily 
controlled with anti-hypertensive drugs. At follow-up, our patient refused percutaneous transluminal renal angioplasty 
as a definitive treatment.
Conclusions: Fibromuscular dysplasia is the most common cause of renovascular hypertension in patients under 50 
years of age. Presentation with renal infarction is rare.
In fibromuscular dysplasia, angioplasty has been proven to have, at least for some indications, an advantage over anti-
hypertensive drugs. Therefore, hypertension secondary to fibromuscular dysplasia is the most common cause of 
curable hypertension.
Introduction
Fibromuscular dysplasia (FMD) describes a group of con-
ditions which cause non-atheromatous arterial stenoses,
most commonly of the renal and internal carotid arteries.
FMD is mostly seen in young women. It typically presents
with hypertension, but presentation with renal infarction
has been described in a handful of cases. The clinical pre-
sentation of renal infarction includes loin pain and fever.
There may be diagnostic delay before diagnosis is made.
W e  r eport  t he  case  o f  F M D pr ese n t ing  wit h unila t e ra l
renal infarction.
Case presentation
A 44-year-old Caucasian (Belgian) man was admitted to
the emergency room, after returning from a trip to
France. Complaints of right loin pain had started two
weeks earlier and were unsuccessfully treated with non-
steroidal anti-inflammatory agents. His past medical his-
tory included arterial hypertension for which the patient
refused medical treatment. He had already started a diet
program in order to lower his blood pressure by losing
weight. His blood pressure on admission was 191/106
mmHg, pulse was regular and temperature was 37.5°C.
His kidney function was slightly impaired with an esti-
mated glomerular filtration rate (GFR) of 71 mL/min/
1.73 m2 (abbreviated modification of diet in renal disease
(MDRD) formula), a moderate leukocytosis (10,700/
mm3) and slight elevation of C-reactive protein (CRP)
(1.9 mg/dL), besides elevated plasma concentrations of
lactate dehydrogenase (639 U/L). A computerized tomog-
raphy (CT) scan demonstrated three wedge shaped areas
of low attenuation in the right kidney, and a 'string of
beads' sign of the right renal artery with suspicion of peri-
arterial inflammatory changes (Figure 1). A sequential
angiography with digital subtraction was performed,
which confirmed the diagnosis of FMD of the right renal
artery (Figure 2). In addition, an intra-luminal thrombus
in the upper right renal artery was observed. Intravenous
therapy with heparin was started and his blood pressure
was easily controlled pharmacologically. Additional
thrombophilia screening (anti-cardiolipin antibodies,
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lupus anticoagulant, anti-thrombin III, factor V Leiden
and levels of proteins C and S) turned out to be negative.
Echocardiography showed left ventricular hypertrophy
with normal left ventricular function. Our patient was
discharged a few days later with oral anticoagulation and
the combination of two classes of anti-hypertensive
drugs. During follow-up, his blood pressure remained
perfectly under control. We advised the patient to
undergo a new angiography in order to evaluate if the
thrombus had resolved and to treat aneurysms and
hemodynamically significant stenotic regions.
Discussion
FMD is a multifactorial arteriopathy that primarily affects
small and medium-sized arteries. It is most common in
the renal and internal carotid arteries, but has been
described in almost every arterial bed in the body.
The first description of FMD has been attributed to
Leadbetter and Burkland in 1938 [1]. The term fibromus-
cular dysplasia was introduced in 1958 in McCornack
and associates' description of three patients with hyper-
tension and renal artery stenosis [2].
FMD is most often diagnosed in the renal arteries,
accounting for 60 to 75% of cases. Involvement of extra-
cranial cerebrovascular arteries accounts for 25 to 30% of
cases, and miscellaneous other arteries (mesenteric or
brachial arteries) for up to 30%. Approximately 25% of
patients have multiple arteries involved. The exact inci-
dence of asymptomatic FMD throughout the arterial cir-
culation is unknown. Renal artery involvement has been
identified through angiographic evaluation of asymptom-
atic, non-hypertensive potential renal donors by two
study groups [3,4]. The reported prevalence was 4.4 to
6.6%. Among adults, FMD is more common among
women, with a prevalence two to ten times higher com-
pared to men. There does not appear to be a female pre-
dominance in children [5]. Most cases of FMD are
diagnosed in patients younger than 50 years, with the
exception of FMD of the cerebral circulation. FMD of the
renal arteries is bilateral in 35 to 50%, and among those
with bilateral disease, nearly half have extra-renal
involvement [3,5].
The cause of FMD is unknown and is probably multi-
factorial. The most commonly held hypothesis includes
hormonal, ischemic, mechanical and genetic factors.
The pathological classification is based on the predom-
inantly involved arterial wall layer. The lesions generally
are classified into four types. Macro-aneurysms and dis-
sections are complications of FMD, and do not represent
distinct histopathological categories.
Medial fibroplasia is characterized by the classic angio-
graphical 'string of beads' appearance, and represents the
most common dysplastic lesion. It is typically located in
the middle-to-distal portion of the artery. Intimal fibro-
plasia occurs in less than 10% of patients with arterial
fibrodysplasia. Angiographically, it may appear as a focal,
concentric stenosis and is often bilateral. Perimedial dys-
plasia accounts for 10% of the lesion in renal arteries. On
angiography, multiple high-grade stenoses of the main
renal artery without aneurysmal dilatation are seen.
Adventitial hyperplasia is the rarest type of fibrodys-
plastic lesion. There is limited angiographic information.
Figure 1 White arrow: right renal infarction. Dotted white arrow: 
nodular aspect of the right renal artery.
Figure 2 White arrow: typical string of beads pattern of the right 
renal artery. Dotted white arrow: thrombus formation in the right up-
per renal artery. Short black arrow: aneurysm formation. Long black ar-
row: renal infarction due to thrombus formation of the right middle 
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Sharply localized, tubular areas of stenosis have been
observed.
Renal infarction in the general population commonly
results from thromboembolism due to structural or
arrythmical cardiac disease, but it is also associated with
coagulation disorders, vasculitis, trauma and conditions
of blood vessel dysfunction, such as Marfan syndrome,
Ehlers-Danlos syndrome and, as presented in this case,
FMD [6-8]. Progression to renal infarction in FMD is
rare. Most patients who develop renal infarction have
perimedial dysplasia [9]. In perimedial dysplasia, large
parts of the media are replaced by collagen, with irregular
thickening of the media which may lead to total occlu-
sion. Also intimal dysplasia seems to have a worse prog-
n o s i s .  I t  i s  c a u s e d  b y  c i r c u m f e r e n t i a l  o r  e c c e n t r i c
deposition of collagen in the intima and usually affects
multiple renal artery braches. So, it is more likely to
develop dissections or dangerous ischemic nephropathy
[10]. But also in medial fibrodysplasia renal infarction has
been reported. In this type of FMD, there are alternating
fibromuscular webs and aneurysmal dilatation. The aneu-
rysms seen in FMD are all true aneurysms. Renal infarc-
tion can result from embolization from the aneurysm sac.
In areas of alternating stenosis and dilatation, shear-
induced platelet activation precipitates thrombus forma-
tion [11].
In most cases, individuals with FMD have been asymp-
tomatic for many years and the diagnosis is made inci-
dentally during the investigation of another problem.
Disease manifestations may result from ischemia related
to stenosis, spontaneous dissection of arteries, rupture of
aneurysms or embolization of intra-vascular thrombi
from aneurysmal segments. The primary clinical mani-
festation of renal FMD is hypertension. Often, hyperten-
sion tends to be refractory to simple drug therapy. As in
atherosclerotic renovascular occlusive disease, use of an
angiotensin-converting enzyme (ACE)-inhibitor can
often worsen renal function in bilateral disease. Loss of
renal function occurs in up to 63% of patients with renal
a r t e r y  F M D ,  b u t  o v e r t  r e n a l  f a i l u r e  i s  r a r e  i n  t h e s e
patients. FMD presenting as a renal infarction is quite
exceptional. Flank pain occurs in the majority of these
patients. Fever, vomiting, and oliguria constitute other
symptoms. Hematuria arises in roughly 50% of cases.
Lactate dehydrogenase is elevated in most cases.
The gold standard for evaluating renal artery FMD
remains digital subtraction angiography.
The main impetus for the treatment of FMD is control
of hypertension. The treatment for most patients can be
primarily managed medically [12]. The principles of drug
therapy are based on the pathophysiology of renal artery
stenosis and the Renin-Angiotensin-Aldosterone-System
(RAAS). In patients with unilateral stenosis, renin-angio-
tensin mediated vasoconstriction is the primary mecha-
nism of hypertension. The normal contra-lateral kidney
is able to produce a natriuresis, thus avoiding aldoster-
one-mediated volume retention. In case of bilateral
stenoses, the natriuresis cannot occur, leading to sodium
and volume retention, which is the main mechanism of
hypertension in these patients. In conclusion, ACE-inhib-
itors should be first-line agents in the former case, as
diuretics should be in the latter form.
Percutaneous transluminal renal angioplasty (PTRA)
should be considered in well-defined groups of patients:
those with a recent onset of hypertension (in particular
patients younger than 50 who are less likely to have
underlying atherosclerotic disease) in whom the goal is to
cure the hypertension; those in whom blood pressure
control had proved to be difficult despite the use of a
combination of anti-hypertensive drugs; those with an
intolerance to anti-hypertensive medications and those
who have lost renal volume because of ischemic nephrop-
athy. In patients with relatively well-controlled hyperten-
sion, or with no loss of renal parenchymal mass, the risk
of the procedure may outweigh the benefits. Angioplasty
is generally sufficient and stenting is only performed
when there is a suboptimal balloon result or flow-limiting
dissection. The reported success rates for PTRA range
from 83 to 100% [12-17]. Overall cure and improvement/
benefit rates for hypertension vary from 22 to 94% and
depend on the definition that is given to 'cured' and
'improved' [17-22]. Comparison between studies is there-
fore not easy and often inaccurate. The rate of restenosis,
following PTRA ranges from 6.7 to 23% [12,14,15,17-19].
Complications of angioplasty include renal artery dissec-
tion and perforation, contrast nephropathy, and hema-
toma or pseudo-aneurysm formation at the access site.
Some authors mention macro-aneurysms, branch vessel
disease and complex dissections as contra-indications for
PTRA [13]. Others claim that PTRA is equally effective in
the main renal artery and in branch-artery stenoses [17].
A recent retrospective study showed that long duration of
hypertension, high age and FMD involvement of branch
arteries negatively affect efficacy of treatment [16]. On
the other hand, predictors of long-term clinical benefit
seem to be: duration of hypertension < 8 years, serum
creatinine <1.5 mg/dL and functional status of the con-
tra-lateral kidney.
Conclusions
In this case report, we presented a case of renal infarction
complicating FMD. This rare combination has only been
described in a handful of cases [21,22]. The typical fea-
tures of acute renal infarction include persistent abdomi-
nal, flank or lower back pain. Early recognition is
primordial in this patient group (predominantly less than
50 years of age). In our patient, blood pressure was easily
controlled by two classes of oral anti-hypertensive agents.Van den Driessche et al. Journal of Medical Case Reports 2010, 4:199
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D u r i n g  f o l l o w - u p ,  b l o o d  p r e s s u r e  r e m a i n e d  p e r f e c t l y
controlled. However, a redo-angiography has to be per-
f o r m e d ,  a s  i t  i s  i m p o r t a n t  t o  c o n t r o l  i f  t h r o m b u s  h a s
resolved. Moreover, it is necessary to assess hemody-
namic significance of the renal artery stenosis and if so, to
perform a dilatation. In particular, de novo embolization
and recurrent renal infarction has to be prevented.
Unfortunately, our patient refused redo-angiography.
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